Treatment of high myopic choroidal neovascularisation with intravitreal bevacizumab;Traitement des néovaisseaux choroïdiens du myope fort par injection intravitréenne de bevacizumab

Journal Francais d'Ophtalmologie

Volumn 37, Issue 1, 2014, Pages 54-57

  Mathieu, B ^a   Isaico, R ^a   Ramel, J C ^a   Bron, A M ^a   Creuzot Garcher, C ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Anti VEGF; Bevacizumab; Choroidal neovascularization; Myopia

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

AGED; ANTI-VEGF; ARTICLE; DEGENERATIVE MYOPIA; DRUG EFFECT; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MYOPIA; MYOPIE; NÉOVAISSEAUX; NÉOVASCULARISATION CHOROÏDIENNE; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ANTI-VEGF; BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; MYOPIA; MYOPIE; NÉOVAISSEAUX; NÉOVASCULARISATION CHOROÏDIENNE;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84892810590     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2013.07.006     Document Type: Article

References (19)

1. G. Soubrane Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment Surv Ophthalmol 53 2008 121 138
2. S.Y. Cohen, A. Laroche, Y. Leguen, G. Soubrane, and G.J. Coscas Etiology of choroidal neovascularization in young patients Ophthalmology 103 1996 1241 1244
3. W.M. Chan, M. Ohji, T.Y. Lai, D.T. Liu, Y. Tano, and D.S. Lam Choroidal neovascularisation in pathological myopia: an update in management Br J Ophthalmol 89 2005 1522 1528
4. T. Yoshida, K. Ohno-Matsui, K. Yasuzumi, A. Kojima, N. Shimada, and S. Futagami et al. Myopic choroidal neovascularization: a 10-year follow-up Ophthalmology 110 2003 1297 1305
5. M.L. Hotchkiss, and S.L. Fine Pathologic myopia and choroidal neovascularization Am J Ophthalmol 91 1981 177 183
6. o 3 Ophthalmology 110 2003 667 673
7. P.L. Cornut, M. Poli, A. Feldman, H. El Chehab, B. Swalduz, and C. Burillon et al. Traitement des néovaisseaux choroïdiens rétrofovéolaires naïfs du myope fort par injection intravitréenne de ranibizumab: résultats à 12 mois J Fr Ophtalmol 33 2010 327 333
8. J.U. Yoon, Y.J. Byun, and H.J. Koh Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization Retina 30 2010 418 424
9. J.M. Ruiz-Moreno, and J.A. Montero Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome Graefes Arch Clin Exp Ophthalmol 248 2010 937 941
10. P.C. Wu, and Y.J. Chen Intravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-up Eye 23 2009 2042 2045
11. Y. Ikuno, Y. Nagai, S. Matsuda, A. Arisawa, K. Sho, and T. Oshita et al. Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization Am J Ophthalmol 149 2010 140 146
12. J.M. Ruiz-Moreno, and J.A. Montero Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes BrJ Ophthalmol 87 2003 856 859
13. R. Brancato, A. Pece, P. Avanza, and E. Radrizzani Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia Retina 10 1990 239 243
14. M. Rudolf, S. Michels, U. Schlotzer-Schrehardt, and U. Schmidt-Erfurth Expression of angiogenic factors by photodynamic therapy Klin Monbl Augenheilkd 221 2004 1026 1032
15. J.A. Montero, and J.M. Ruiz-Moreno Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study Br J Ophthalmol 91 2007 131 133
16. T. Baba, M. Kubota-Taniai, M. Kitahashi, K. Okada, Y. Mitamura, and S. Yamamoto Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation Br J Ophthalmol 94 2010 864 870
17. S. Mandal, P. Venkatesh, R. Sampangi, and S. Garg Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization Eur J Ophthalmol 17 2007 620 626
18. P. Milani, A. Massacesi, S. Ciaccia, M. Setaccioli, S. Moschini, and F. Bergamini Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naive myopic choroidal neovascularization Clin Ophthalmol 6 2012 1885 1894
19. J.M. Ruiz-Moreno, J.A. Montero, L. Arias, J. Araiz, F. Gomez-Ulla, and R. Silva et al. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization Retina 30 2010 1609 1615